An Economic Analysis of AIDS — Towards a Proposed Model of Costing: A Singapore Experience
- 1 July 1994
- journal article
- Published by SAGE Publications in Asia-Pacific journal of public health
- Vol. 7 (3) , 143-150
- https://doi.org/10.1177/101053959400700301
Abstract
With the increasing prevalence of HIV infection/AIDS and the extending range of care and treatment, the economic implications of the various prevention and control strategies, and of treatment, have become the subject of interest to policy-makers, public health specialists and health economists. This paper presents an overview of the methods used for the economic analysis of AIDS/HIV infection. It proposes an activity-oriented, cost center-based model for the costing of the economic impact of AIDS, using cost figures in Singapore since 1985, when the National AIDS Control Program was started. Priorities for future research are also identified. Asia Pac J Public Health1994;7(3):143-50.Keywords
This publication has 10 references indexed in Scilit:
- Cost and Benefit of Secondary Prophylaxis for Pneumocystis carinii PneumoniaJAMA, 1991
- Improving the cost-effectiveness of AIDS health care in San Juan, Puerto RicoThe Lancet, 1991
- Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) InfectionAnnals of Internal Medicine, 1991
- The Quality of Well-Being ScaleMedical Care, 1989
- Treating AIDS: the economic issuesHealth Policy, 1988
- AIDSAIDS, 1988
- The Economic Impact of the First 10,000 Cases of Acquired Immunodeficiency Syndrome in the United StatesJAMA, 1986